We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Vaxart, Zoom Video Communications, Amazon.com, Clorox and Costco Wholesale
Read MoreHide Full Article
For Immediate Release
Chicago, IL – March 25, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Vaxart Inc. (VXRT - Free Report) , Zoom Video Communications, Inc. (ZM - Free Report) , Amazon.com (AMZN - Free Report) , Clorox (CLX - Free Report) and Costco Wholesale Corp. (COST - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Here Are the 5 Big Winners from the Coronavirus Pandemic
It’s been three months since the onset of the coronavirus outbreak, which has been wreaking havoc, infecting thousands of people, disrupting supply chains and restraining movement between countries. Governments worldwide have struggled to control this health crisis, and resorted to complete lockdowns to check the spread of the pandemic.
The coronavirus outbreak has certainly weighed on corporate profits and hampered economic growth, with many expecting contractions in the first two quarters this year. The past few weeks, in particular, have been brutal for markets. While some businesses are anticipated to take significant time to recover, some have been irrevocably damaged.
Meanwhile, there are businesses that prospered due to the coronavirus pandemic. Here’re five that stand to benefit from the pandemic.
First on our list is Vaxart Inc., which interestingly is known for utilizing tablets instead of injections to deliver vaccines. On Mar 18, the company finalized a deal with Emergent BioSolutions to manufacture COVID-19 vaccine, which helped analysts conclude that it has significant prospects.
Vaxart’s VAAST technology platform and Emergent BioSolutions’ molecule-to-market contract development and manufacturing (CDMO) services will be used to develop the vaccine. Vaxart’s technology, particularly, is helpful as it uses adenovirus type 5 (Ad5), which ultimately boosts immunity.
H.C. Wainwright analyst Vernon Bernardino pointed out that such vaccines will be crucial in the fight against coronavirus, and that Vaxart will benefit from its growing demand in the near term. Wainwright currently has a $3 price target on the stock, which means the stock can surge more than 60% from its current level. By the way, the Zacks Consensus Estimate for Vaxart’s current-year earnings soared 86.4% over the past 60 days. The company, currently, carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Since many businesses have asked their staff to work from home in a bid to minimize the chance of infection, Zoom Video Communications, Inc.’s demand has improved considerably. This is because Zoom provides cloud-based platform for video conferencing that helps workers stay connected from any part of the world.
Many schools across the country have also shut down, and educators are mostly relying on online platforms to engage students. Virtual learning has picked up, and Zoom is providing the necessary platform for that to happen.
Notably, Zoom has been one of the few stocks that saw its shares hit record highs last week, while the broader market tanked. What’s more, the company’s expected earnings growth rate for the current quarter and year is a whopping 233.3% and 17.1%, respectively.
The Zacks Consensus Estimate for the company’s current-year earnings climbed 51.9% over the past 60 days. Currently, Zoom has a Zacks Rank #2.
And with thousands of people staying at home and reluctant to go to stores in fear of contracting the disease, e-commerce giant Amazon.com has been enjoying robust sales. Amazon’s massive supply chain is supplying necessary household items, and in the process is generating promising returns for its shareholders. Needless to say, that Amazon has retail chains across the globe.
Individually, Amazon has been doing pretty good! It is benefiting from its Prime program, delivery and logistic system in the e-commerce space. Further, its dominant position in cloud market remains a positive. The Zacks Rank #3 (Hold) company’s expected earnings growth rate for the next quarter and current year is a solid 20.9% and 20%, respectively.
Despite the current market carnage, Amazon has been able to hold on to its gains. Amazon has outperformed the Internet - Commerce industry so far this year (+3.0% vs -9.7%).
Meanwhile, with the COVID-19 spreading primarily through contact, the best way to prevent it is by cleaning and sanitizing things regularly. Hence, the clean-up of everything from office premises to cruise ships are on in order to rid them of the deadly virus. And this, in turn, has created demand for Clorox’sproducts. After all, Clorox is known for producing bleaching products for cleaning and disinfecting germs.
Clorox, by the way, has already reported a strong second-quarter fiscal 2020 results, wherein both earnings and sales beat the Zacks Consensus Estimate. It has witnessed gross margin expansion of 40 bps in second-quarter fiscal 2020, driven by price increases and cost savings.
Clorox, currently, sports a Zacks Rank #1. The Zacks Consensus Estimate for its current-year earnings increased 2.1% over the past 60 days. Shares of Clorox, in fact, have outpaced the Soap and Cleaning Materials industry on a year-to-date basis (+10.8% vs -15.9%).
It’s worth pointing out that Coronavirus-led panic has compelled consumers in large numbers to go to grocery stores and big warehouses to stock up on staple items, and other household goods. Provisions for necessary items are the need of the hour provided there is a prolonged lockdown! This kind of a situation bodes well for operator of membership warehouses, Costco Wholesale Corp.
To top it, Costco is providing necessary goods at discounted prices, which is benefiting cash-strapped customers. The company’s strategy to provide lost-cost vital products in such a crunch situation shall certainly help its shares gain traction in the near future. Costco’s expected earnings growth rate for the current quarter and year is 7.9% and 6.5%, respectively. The Zacks Consensus Estimate for its current-year earnings increased 1.3% over the past 60 days. Costco, currently, has a Zacks Rank #2.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Vaxart, Zoom Video Communications, Amazon.com, Clorox and Costco Wholesale
For Immediate Release
Chicago, IL – March 25, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Vaxart Inc. (VXRT - Free Report) , Zoom Video Communications, Inc. (ZM - Free Report) , Amazon.com (AMZN - Free Report) , Clorox (CLX - Free Report) and Costco Wholesale Corp. (COST - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
Here Are the 5 Big Winners from the Coronavirus Pandemic
It’s been three months since the onset of the coronavirus outbreak, which has been wreaking havoc, infecting thousands of people, disrupting supply chains and restraining movement between countries. Governments worldwide have struggled to control this health crisis, and resorted to complete lockdowns to check the spread of the pandemic.
The coronavirus outbreak has certainly weighed on corporate profits and hampered economic growth, with many expecting contractions in the first two quarters this year. The past few weeks, in particular, have been brutal for markets. While some businesses are anticipated to take significant time to recover, some have been irrevocably damaged.
Meanwhile, there are businesses that prospered due to the coronavirus pandemic. Here’re five that stand to benefit from the pandemic.
First on our list is Vaxart Inc., which interestingly is known for utilizing tablets instead of injections to deliver vaccines. On Mar 18, the company finalized a deal with Emergent BioSolutions to manufacture COVID-19 vaccine, which helped analysts conclude that it has significant prospects.
Vaxart’s VAAST technology platform and Emergent BioSolutions’ molecule-to-market contract development and manufacturing (CDMO) services will be used to develop the vaccine. Vaxart’s technology, particularly, is helpful as it uses adenovirus type 5 (Ad5), which ultimately boosts immunity.
H.C. Wainwright analyst Vernon Bernardino pointed out that such vaccines will be crucial in the fight against coronavirus, and that Vaxart will benefit from its growing demand in the near term. Wainwright currently has a $3 price target on the stock, which means the stock can surge more than 60% from its current level. By the way, the Zacks Consensus Estimate for Vaxart’s current-year earnings soared 86.4% over the past 60 days. The company, currently, carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Since many businesses have asked their staff to work from home in a bid to minimize the chance of infection, Zoom Video Communications, Inc.’s demand has improved considerably. This is because Zoom provides cloud-based platform for video conferencing that helps workers stay connected from any part of the world.
Many schools across the country have also shut down, and educators are mostly relying on online platforms to engage students. Virtual learning has picked up, and Zoom is providing the necessary platform for that to happen.
Notably, Zoom has been one of the few stocks that saw its shares hit record highs last week, while the broader market tanked. What’s more, the company’s expected earnings growth rate for the current quarter and year is a whopping 233.3% and 17.1%, respectively.
The Zacks Consensus Estimate for the company’s current-year earnings climbed 51.9% over the past 60 days. Currently, Zoom has a Zacks Rank #2.
And with thousands of people staying at home and reluctant to go to stores in fear of contracting the disease, e-commerce giant Amazon.com has been enjoying robust sales. Amazon’s massive supply chain is supplying necessary household items, and in the process is generating promising returns for its shareholders. Needless to say, that Amazon has retail chains across the globe.
Individually, Amazon has been doing pretty good! It is benefiting from its Prime program, delivery and logistic system in the e-commerce space. Further, its dominant position in cloud market remains a positive. The Zacks Rank #3 (Hold) company’s expected earnings growth rate for the next quarter and current year is a solid 20.9% and 20%, respectively.
Despite the current market carnage, Amazon has been able to hold on to its gains. Amazon has outperformed the Internet - Commerce industry so far this year (+3.0% vs -9.7%).
Meanwhile, with the COVID-19 spreading primarily through contact, the best way to prevent it is by cleaning and sanitizing things regularly. Hence, the clean-up of everything from office premises to cruise ships are on in order to rid them of the deadly virus. And this, in turn, has created demand for Clorox’sproducts. After all, Clorox is known for producing bleaching products for cleaning and disinfecting germs.
Clorox, by the way, has already reported a strong second-quarter fiscal 2020 results, wherein both earnings and sales beat the Zacks Consensus Estimate. It has witnessed gross margin expansion of 40 bps in second-quarter fiscal 2020, driven by price increases and cost savings.
Clorox, currently, sports a Zacks Rank #1. The Zacks Consensus Estimate for its current-year earnings increased 2.1% over the past 60 days. Shares of Clorox, in fact, have outpaced the Soap and Cleaning Materials industry on a year-to-date basis (+10.8% vs -15.9%).
It’s worth pointing out that Coronavirus-led panic has compelled consumers in large numbers to go to grocery stores and big warehouses to stock up on staple items, and other household goods. Provisions for necessary items are the need of the hour provided there is a prolonged lockdown! This kind of a situation bodes well for operator of membership warehouses, Costco Wholesale Corp.
To top it, Costco is providing necessary goods at discounted prices, which is benefiting cash-strapped customers. The company’s strategy to provide lost-cost vital products in such a crunch situation shall certainly help its shares gain traction in the near future. Costco’s expected earnings growth rate for the current quarter and year is 7.9% and 6.5%, respectively. The Zacks Consensus Estimate for its current-year earnings increased 1.3% over the past 60 days. Costco, currently, has a Zacks Rank #2.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.